期刊
JOURNAL OF PHARMACEUTICAL SCIENCES
卷 98, 期 3, 页码 812-843出版社
ELSEVIER SCIENCE INC
DOI: 10.1002/jps.21493
关键词
vaccines; intranasal delivery; particulate systems; liposomes; nanoparticles; microparticles; adjuvants; industrial aspects
The nasal route offers a promising opportunity for the delivery of vaccines. This review analyses the opportunities and novel delivery strategies based on particulate systems for the nasal delivery of vaccines, including liposomes, proteosomes, virosomes, nano- and microparticulate systems, with and without adjuvants. The influence of pharmaceutical aspects of the particulate formulations on nasal delivery is analysed. Recently developed delivery devices for nasal vaccination are also described. Potential barriers to clinical and commercial success of some novel intranasal vaccines are critically evaluated. Although particulate systems may offer potential in the nasal delivery of vaccines by enhancing uptake by antigen-presenting cells, the real success in enhancement of vaccine delivery can only be achieved by careful design and manipulation of physicochemical properties of particulate vaccine delivery systems. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:812-843, 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据